CBMX

NIH Studies in New England Journal of Medicine Favor Chromosomal Microarray Analysis Over Standard Karyotyping for Genetic Analysis

[at noodls] – Largest Head-to-Head Studies Comparing the Two Diagnostic Tools; CombiMatrix: Only Publicly-Traded Diagnostic Laboratory Specializing in Microarray Analysis IRVINE, Calif., Dec. 7, 2012 (GLOBE NEWSWIRE) … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboardSee who CombiMatrix is hiring next, click here to view […]

CombiMatrix Stockholders Approve Second Tranche of Series A Preferred Stock Financing; Announces 1-for-10 Reverse Split of Common Stock and Nasdaq-Listed Warrants

[at noodls] – CombiMatrix Stockholders Approve Second Tranche of Series A Preferred Stock Financing; Announces 1-for-10 Reverse Split of Common Stock and Nasdaq-Listed Warrants IRVINE, Calif., Dec. 4, 2012 (GLOBE NEWSWIRE) … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboardSee who CombiMatrix is hiring next, click here to view […]

CombiMatrix to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

[at noodls] – CombiMatrix to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum IRVINE, Calif., Nov. 28, 2012 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboard […]

CombiMatrix Appoints Jeremy M. Jones to Board of Directors

[at noodls] – Senior Healthcare Services Executive Brings 35 Plus Years Industry Experience to Board IRVINE, Calif., Nov. 26, 2012 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboard […]

CombiMatrix Corporation Reports Results for 2012 Third Quarter

[at noodls] – Core Prenatal Testing Grew 73% Year-Over-Year in Third Quarter IRVINE, Calif., Nov. 7, 2012 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboard […]

CombiMatrix and Pathology, Inc. Form Partnership to Market and Distribute Prenatal Tests

[at noodls] – CombiMatrix and Pathology, Inc. Form Partnership to Market and Distribute Prenatal Tests Pathology, Inc. Will Market Chromosomal Microarray for Products of Conception Testing Market in Nevada, California, … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboard […]

CombiMatrix Corporation to Release Third Quarter and Nine-Month Financial Results on November 7, 2012

[at noodls] – CombiMatrix Corporation to Release Third Quarter and Nine-Month Financial Results on November 7, 2012 IRVINE, Calif., Oct. 31, 2012 (GLOBE NEWSWIRE) — CombiMatrix Corporation (Nasdaq:CBMX) announced today … moreView todays social media effects on CBMXView the latest stocks trending across Twitter. Click to view dashboard […]